{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T07:15:33Z","timestamp":1768720533626,"version":"3.49.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,2,27]],"date-time":"2019-02-27T00:00:00Z","timestamp":1551225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s00280-019-03787-5","type":"journal-article","created":{"date-parts":[[2019,2,27]],"date-time":"2019-02-27T21:39:46Z","timestamp":1551303586000},"page":"893-904","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Irinotecan induces enterocyte cell death and changes to muc2 and muc4 composition during mucositis in a tumour-bearing DA rat model"],"prefix":"10.1007","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5644-6170","authenticated-orcid":false,"given":"Daniel","family":"Thorpe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masooma","family":"Sultani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Stringer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,27]]},"reference":[{"issue":"3","key":"3787_CR1","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s00280-006-0275-9","volume":"59","author":"JM Bowen","year":"2007","unstructured":"Bowen JM, Gibson RJ, Cummins AG, Tyskin A, Keefe DM (2007) \u201cIrinotecan changes gene expression in the small intestine of the rat with breast cancer\u201d. Cancer Chemother Pharmacol 59(3):337\u2013348","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1","key":"3787_CR2","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1080\/00313020400023461","volume":"37","author":"JM Bowen","year":"2005","unstructured":"Bowen JM, Gibson RJ, Keefe DM, Cummins AG (2005) Cytotoxic chemotherapy upregulates pro-apoptotic Bax and Bak in the small intestine of rats and humans. Pathology 37(1):56\u201362","journal-title":"Pathology"},{"issue":"Pt 2","key":"3787_CR3","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1042\/bj3230521","volume":"323","author":"JE Branka","year":"1997","unstructured":"Branka JE, Vallette G, Jarry A, Laboisse CL (1997) Stimulation of mucin exocytosis from human epithelial cells by nitric oxide: evidence for a cGMP-dependent and a cGMP-independent pathway. Biochem J 323(Pt 2):521\u2013524","journal-title":"Biochem J"},{"key":"3787_CR4","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0079-6603(02)71043-X","volume":"71","author":"KL Carraway","year":"2002","unstructured":"Carraway KL, Perez A, Idris N, Jepson S, Arango M, Komatsu M, Haq B, Price-Schiavi SA, Zhang J, Carraway CA (2002) Muc4\/sialomucin complex, the intramembrane ErbB2 ligand, in cancer and epithelia: to protect and to survive. Prog Nucleic Acid Res Mol Biol 71:149\u2013185","journal-title":"Prog Nucleic Acid Res Mol Biol"},{"key":"3787_CR5","doi-asserted-by":"publisher","DOI":"10.4324\/9780203771587","volume-title":"Statistical power analysis for the behavioral sciences","author":"J Cohen","year":"2013","unstructured":"Cohen J (2013) Statistical power analysis for the behavioral sciences. Taylor and Francis, London"},{"issue":"1","key":"3787_CR6","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1002\/jcp.20822","volume":"210","author":"BA Koning de","year":"2007","unstructured":"de Koning BA, Sluis M, Lindenbergh-Kortleve DJ, Velcich A, Pieters R, Buller HA, Einerhand AW, Renes IB (2007) Methotrexate-induced mucositis in mucin 2-deficient mice. J Cell Physiol 210(1):144\u2013152","journal-title":"J Cell Physiol"},{"issue":"7","key":"3787_CR7","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1002\/cncr.11671","volume":"98","author":"LS Elting","year":"2003","unstructured":"Elting LS, Cooksley C, Chambers M, Cantor SB, Manzullo E, Rubenstein EB (2003) The burdens of cancer therapy. Clinical economic outcomes of chemotherapy-induced mucositis. Cancer 98(7):1531\u20131539","journal-title":"Cancer"},{"issue":"4","key":"3787_CR8","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.ijrobp.2007.01.053","volume":"68","author":"LS Elting","year":"2007","unstructured":"Elting LS, Cooksley CD, Chambers MS, Garden AS (2007) Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies. Int J Radiat Oncol Biol Phys 68(4):1110\u20131120","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"3787_CR9","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1159\/000107458","volume":"53","author":"RJ Gibson","year":"2007","unstructured":"Gibson RJ, Bowen JM, Alvarez E, Finnie J, Keefe DM (2007) Establishment of a single-dose irinotecan model of gastrointestinal mucositis. Chemotherapy 53(5):360\u2013369","journal-title":"Chemotherapy"},{"issue":"3","key":"3787_CR10","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1002\/ijc.21082","volume":"116","author":"RJ Gibson","year":"2005","unstructured":"Gibson RJ, Bowen JM, Keefe DM (2005) Palifermin reduces diarrhea and increases survival following irinotecan treatment in tumor-bearing DA rats. Int J Cancer 116(3):464\u2013470","journal-title":"Int J Cancer"},{"issue":"1","key":"3787_CR11","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s00280-002-0460-4","volume":"50","author":"RJ Gibson","year":"2002","unstructured":"Gibson RJ, Keefe DM, Clarke JM, Regester GO, Thompson FM, Goland GJ, Edwards BG, Cummins AG (2002) The effect of keratinocyte growth factor on tumour growth and small intestinal mucositis after chemotherapy in the rat with breast cancer. Cancer Chemother Pharmacol 50(1):53\u201358","journal-title":"Cancer Chemother Pharmacol"},{"issue":"12","key":"3787_CR12","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.1023\/A:1021061306913","volume":"47","author":"RJ Gibson","year":"2002","unstructured":"Gibson RJ, Keefe DM, Thompson FM, Clarke JM, Goland GJ, Cummins AG (2002) Effect of interleukin-11 on ameliorating intestinal damage after methotrexate treatment of breast cancer in rats. Dig Dis Sci 47(12):2751\u20132757","journal-title":"Dig Dis Sci"},{"issue":"3","key":"3787_CR13","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/j.1582-4934.2001.tb00169.x","volume":"5","author":"JR Jass","year":"2001","unstructured":"Jass JR, Walsh MD (2001) Altered mucin expression in the gastrointestinal tract: a review. J Cell Mol Med 5(3):327\u2013351","journal-title":"J Cell Mol Med"},{"issue":"1","key":"3787_CR14","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s00520-003-0550-9","volume":"12","author":"DM Keefe","year":"2004","unstructured":"Keefe DM (2004) Gastrointestinal mucositis: a new biological model. Support Care Cancer 12(1):6\u20139","journal-title":"Support Care Cancer"},{"issue":"5","key":"3787_CR15","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1136\/gut.47.5.632","volume":"47","author":"DM Keefe","year":"2000","unstructured":"Keefe DM, Brealey J, Goland GJ, Cummins AG (2000) Chemotherapy for cancer causes apoptosis that precedes hypoplasia in crypts of the small intestine in humans. Gut 47(5):632\u2013637","journal-title":"Gut"},{"issue":"4","key":"3787_CR16","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1042\/cs0920385","volume":"92","author":"DM Keefe","year":"1997","unstructured":"Keefe DM, Cummins AG, Dale BM, Kotasek D, Robb TA, Sage RE (1997) Effect of high-dose chemotherapy on intestinal permeability in humans. Clin Sci (Lond) 92(4):385\u2013389","journal-title":"Clin Sci (Lond)"},{"issue":"5","key":"3787_CR17","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1002\/cncr.22484","volume":"109","author":"DM Keefe","year":"2007","unstructured":"Keefe DM, Schubert MM, Elting LS, Sonis ST, Epstein JB, Raber-Durlacher JE, Migliorati CA, McGuire DB, Hutchins RD, Peterson DE (2007) Updated clinical practice guidelines for the prevention treatment of mucositis. Cancer 109(5):820\u2013831","journal-title":"Cancer"},{"issue":"3","key":"3787_CR18","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1177\/0148607188012003286","volume":"12","author":"KA Kern","year":"1988","unstructured":"Kern KA, Norton JA (1988) Cancer cachexia. JPEN J Parenter Enteral Nutr 12(3):286\u2013298","journal-title":"JPEN J Parenter Enteral Nutr"},{"issue":"1\u20132","key":"3787_CR19","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.cellimm.2009.01.001","volume":"256","author":"YY Li","year":"2009","unstructured":"Li YY, Hsieh LL, Tang RP, Liao SK, Yeh KY (2009) Macrophage-derived interleukin-6 up-regulates MUC1, but down-regulates MUC2 expression in the human colon cancer HT-29 cell line. Cell Immunol 256(1\u20132):19\u201326","journal-title":"Cell Immunol"},{"issue":"4","key":"3787_CR20","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s00280-011-1780-z","volume":"69","author":"RC Lima-Junior","year":"2012","unstructured":"Lima-Junior RC, Figueiredo AA, Freitas HC, Melo ML, Wong DV, Leite CA, Medeiros RP, Marques-Neto RD, Vale ML, Brito GA, Oria RB, Souza MH, Cunha FQ, Ribeiro RA (2012) Involvement of nitric oxide on the pathogenesis of irinotecan-induced intestinal mucositis: role of cytokines on inducible nitric oxide synthase activation. Cancer Chemother Pharmacol 69(4):931\u2013942","journal-title":"Cancer Chemother Pharmacol"},{"issue":"7","key":"3787_CR21","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.4161\/cbt.7.7.6207","volume":"7","author":"RM Logan","year":"2008","unstructured":"Logan RM, Stringer AM, Bowen JM, Gibson RJ, Sonis ST, Keefe DM (2008) Serum levels of NFkappaB and pro-inflammatory cytokines following administration of mucotoxic drugs. Cancer Biol Ther 7(7):1139\u20131145","journal-title":"Cancer Biol Ther"},{"issue":"2","key":"3787_CR22","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00280-008-0732-8","volume":"63","author":"RM Logan","year":"2009","unstructured":"Logan RM, Stringer AM, Bowen JM, Gibson RJ, Sonis ST, Keefe DM (2009) Is the pathobiology of chemotherapy-induced alimentary tract mucositis influenced by the type of mucotoxic drug administered? Cancer Chemother Pharmacol 63(2):239\u2013251","journal-title":"Cancer Chemother Pharmacol"},{"issue":"10","key":"3787_CR23","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1172\/JCI119782","volume":"100","author":"C Nathan","year":"1997","unstructured":"Nathan C (1997) Inducible nitric oxide synthase: what difference does it make?. J Clin Invest 100(10):2417\u20132423","journal-title":"J Clin Invest"},{"issue":"8","key":"3787_CR24","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1111\/j.1365-2362.1992.tb01504.x","volume":"22","author":"G Ollenschlager","year":"1992","unstructured":"Ollenschlager G, Thomas W, Konkol K, Diehl V, Roth E (1992) Nutritional behaviour and quality of life during oncological polychemotherapy: results of a prospective study on the efficacy of oral nutrition therapy in patients with acute leukaemia. Eur J Clin Invest 22(8):546\u2013553","journal-title":"Eur J Clin Invest"},{"key":"3787_CR25","first-page":"87","volume-title":"A-Z of quantitative PCR","author":"MW Pfaffl","year":"2004","unstructured":"Pfaffl MW (2004) Quantification strategies in real-time PCR. In: Bustin S (ed) A-Z of quantitative PCR. International University Line, La Jolla, pp 87\u2013112"},{"issue":"6","key":"3787_CR26","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1634\/theoncologist.3-6-446","volume":"3","author":"JL Pico","year":"1998","unstructured":"Pico JL, Avila-Garavito A, Naccache P (1998) Mucositis: its occurrence, consequences, and treatment in the oncology setting. Oncologist 3(6):446\u2013451","journal-title":"Oncologist"},{"issue":"5 Pt 1","key":"3787_CR27","first-page":"G1073","volume":"275","author":"P Plaisancie","year":"1998","unstructured":"Plaisancie P, Barcelo A, Moro F, Claustre J, Chayvialle JA, Cuber JC (1998) Effects of neurotransmitters, gut hormones, and inflammatory mediators on mucus discharge in rat colon. Am J Physiol 275(5 Pt 1):G1073\u2013G1084","journal-title":"Am J Physiol"},{"issue":"Pt 2","key":"3787_CR28","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1042\/BJ20040605","volume":"384","author":"C Robbe","year":"2004","unstructured":"Robbe C, Capon C, Coddeville B, Michalski JC (2004) Structural diversity and specific distribution of O-glycans in normal human mucins along the intestinal tract. Biochem J 384(Pt 2):307\u2013316","journal-title":"Biochem J"},{"issue":"4","key":"3787_CR29","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1155\/1997\/642360","volume":"11","author":"AM Robertson","year":"1997","unstructured":"Robertson AM, Wright DP (1997) Bacterial glycosulphatases and sulphomucin degradation. Can J Gastroenterol 11(4):361\u2013366","journal-title":"Can J Gastroenterol"},{"issue":"5","key":"3787_CR30","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1080\/00365520701811693","volume":"43","author":"Y Saegusa","year":"2008","unstructured":"Saegusa Y, Ichikawa T, Iwai T, Goso Y, Ikezawa T, Nakano M, Shikama N, Saigenji K, Ishihara K (2008) Effects of acid antisecretory drugs on mucus barrier of the rat against 5-fluorouracil-induced gastrointestinal mucositis. Scand J Gastroenterol 43(5):531\u2013537","journal-title":"Scand J Gastroenterol"},{"issue":"1","key":"3787_CR31","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1080\/00365520701579662","volume":"43","author":"Y Saegusa","year":"2008","unstructured":"Saegusa Y, Ichikawa T, Iwai T, Goso Y, Okayasu I, Ikezawa T, Shikama N, Saigenji K, Ishihara K (2008) Changes in the mucus barrier of the rat during 5-fluorouracil-induced gastrointestinal mucositis. Scand J Gastroenterol 43(1):59\u201365","journal-title":"Scand J Gastroenterol"},{"issue":"Suppl 3","key":"3787_CR32","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1016\/0959-8049(96)00294-8","volume":"32A","author":"L Saltz","year":"1996","unstructured":"Saltz L, Shimada Y, Khayat D (1996) CPT-11 (irinotecan) and 5-fluorouracil: a promising combination for therapy of colorectal cancer. Eur J Cancer 32A(Suppl 3):S24\u2013S31","journal-title":"Eur J Cancer"},{"issue":"1","key":"3787_CR33","first-page":"35","volume":"1","author":"LB Saltz","year":"2003","unstructured":"Saltz LB (2003) Understanding and managing chemotherapy-induced diarrhea. J Support Oncol 1(1):35\u201346 (discussion 38\u201341, 45\u201336)","journal-title":"J Support Oncol"},{"key":"3787_CR34","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12957-015-0529-2","volume":"13","author":"A Sanguinetti","year":"2015","unstructured":"Sanguinetti A, Santini D, Bonafe M, Taffurelli M, Avenia N (2015) \u201cInterleukin-6 and pro inflammatory status in the breast tumor microenvironment\u201d. World J Surg Oncol 13:129","journal-title":"World J Surg Oncol"},{"issue":"8","key":"3787_CR35","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1200\/JCO.1997.15.8.2981","volume":"15","author":"DM Savarese","year":"1997","unstructured":"Savarese DM, Hsieh C, Stewart FM (1997) Clinical impact of chemotherapy dose escalation in patients with hematologic malignancies and solid tumors. J Clin Oncol 15(8):2981\u20132995","journal-title":"J Clin Oncol"},{"issue":"6","key":"3787_CR36","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/0030-4220(92)90402-C","volume":"74","author":"ST Sonis","year":"1992","unstructured":"Sonis ST, Costa JW Jr, Evitts SM, Lindquist LE, Nicolson M (1992) Effect of epidermal growth factor on ulcerative mucositis in hamsters that receive cancer chemotherapy. Oral Surg Oral Med Oral Pathol 74(6):749\u2013755","journal-title":"Oral Surg Oral Med Oral Pathol"},{"issue":"9 Suppl","key":"3787_CR37","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1002\/cncr.20162","volume":"100","author":"ST Sonis","year":"2004","unstructured":"Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert M, Hauer-Jensen M, Bekele BN, Raber-Durlacher J, Donnelly JP, Rubenstein EB (2004) Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 100(9 Suppl):1995\u20132025","journal-title":"Cancer"},{"issue":"2 Pt 1","key":"3787_CR38","doi-asserted-by":"publisher","first-page":"C183","DOI":"10.1152\/ajpcell.1991.260.2.C183","volume":"260","author":"RD Specian","year":"1991","unstructured":"Specian RD, Oliver MG (1991) Functional biology of intestinal goblet cells. Am J Physiol 260(2 Pt 1):C183\u2013C193","journal-title":"Am J Physiol"},{"issue":"5","key":"3787_CR39","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/j.1365-2613.2009.00671.x","volume":"90","author":"AM Stringer","year":"2009","unstructured":"Stringer AM, Gibson RJ, Bowen JM, Logan RM, Ashton K, Yeoh AS, Al-Dasooqi N, Keefe DM (2009) Irinotecan-induced mucositis manifesting as diarrhoea corresponds with an amended intestinal flora and mucin profile. Int J Exp Pathol 90(5):489\u2013499","journal-title":"Int J Exp Pathol"},{"issue":"4","key":"3787_CR40","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3181\/0810-RM-301","volume":"234","author":"AM Stringer","year":"2009","unstructured":"Stringer AM, Gibson RJ, Logan RM, Bowen JM, Yeoh AS, Hamilton J, Keefe DM (2009) Gastrointestinal microflora and mucins may play a critical role in the development of 5-Fluorouracil-induced gastrointestinal mucositis. Exp Biol Med (Maywood) 234(4):430\u2013441","journal-title":"Exp Biol Med (Maywood)"},{"issue":"12","key":"3787_CR41","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.4161\/cbt.7.12.6940","volume":"7","author":"AM Stringer","year":"2008","unstructured":"Stringer AM, Gibson RJ, Logan RM, Bowen JM, Yeoh AS, Keefe DM (2008) Faecal microflora and beta-glucuronidase expression are altered in an irinotecan-induced diarrhea model in rats. Cancer Biol Ther 7(12):1919\u20131925","journal-title":"Cancer Biol Ther"},{"issue":"1","key":"3787_CR42","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00280-008-0855-y","volume":"64","author":"AM Stringer","year":"2009","unstructured":"Stringer AM, Gibson RJ, Logan RM, Bowen JM, Yeoh AS, Laurence J, Keefe DM (2009) Irinotecan-induced mucositis is associated with changes in intestinal mucins. Cancer Chemother Pharmacol 64(1):123\u2013132","journal-title":"Cancer Chemother Pharmacol"},{"issue":"5","key":"3787_CR43","doi-asserted-by":"publisher","first-page":"G1037","DOI":"10.1152\/ajpgi.2000.279.5.G1037","volume":"279","author":"M Verburg","year":"2000","unstructured":"Verburg M, Renes IB, Meijer HP, Taminiau JA, Buller HA, Einerhand AW, Dekker J (2000) Selective sparing of goblet cells and paneth cells in the intestine of methotrexate-treated rats. Am J Physiol Gastrointest Liver Physiol 279(5):G1037\u2013G1047","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"9","key":"3787_CR44","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.1200\/JCO.1998.16.9.3169","volume":"16","author":"S Wadler","year":"1998","unstructured":"Wadler S, Benson AB 3rd, Engelking C, Catalano R, Field M, Kornblau SM, Mitchell E, Rubin J, Trotta P, Vokes E (1998) Recommended guidelines for the treatment of chemotherapy-induced diarrhea. J Clin Oncol 16(9):3169\u20133178","journal-title":"J Clin Oncol"},{"key":"3787_CR45","first-page":"276186","volume":"2013","author":"H Yamamoto","year":"2013","unstructured":"Yamamoto H, Ishihara K, Takeda Y, Koizumi W, Ichikawa T (2013) Changes in the mucus barrier during cisplatin-induced intestinal mucositis in rats. Biomed Res Int 2013:276186","journal-title":"Biomed Res Int"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-019-03787-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-019-03787-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-019-03787-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,26]],"date-time":"2020-02-26T19:09:52Z","timestamp":1582744192000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-019-03787-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,27]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["3787"],"URL":"https:\/\/doi.org\/10.1007\/s00280-019-03787-5","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,27]]},"assertion":[{"value":"3 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Daniel Thorpe declares that he has no conflict of interest, Ms. Masooma Sultani declares that she has no conflict of interest, and Dr. Andrea Stringer declares that she has no conflict of interest. Furthermore, all applicable international, national, and\/or institutional guidelines for the care and use of animals were followed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}